[The study also suggests TP53 as a potential molecular marker and prognostic tool, at least in a subset of sporadic breast tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE